Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASE1 | P07998 | 1/20 | 0.69 |
| ▸ | TK1 | P04183 | 6/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | ALB | P02768 | 1/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19132672 | 1.00 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL523268 | 1.00 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL16359947 | 1.00 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL25756080 | 1.00 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL523267 | 1.00 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL10431982 | 1.00 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL8996152 | 0.91 | RNASE1 (0.70) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL22992460 | 0.91 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL4286458 | 0.91 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB | |
| SCHEMBL2056647 | 0.91 | RNASE1 (0.69) | RNASE1TK1LMNATSHRALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026421-A1 | METHODS FOR CAPTURING LONG POLYNUCLEOTIDES FOR SEQUENCING SPECIFIC GENOMIC REGIONS | GENERATION BIOTECH, LLC (US) | 2024-01-25 | — | — | US | disclosed |
| US-11821023-B2 | Method for capturing long polynucleotides for sequencing specific gnomic regions | GENERATION BIOTECH, LLC (US) | 2023-11-21 | — | — | US | disclosed |
| EP-3122759-B1 | CHEMICAL METHODS FOR PRODUCING TAGGED NUCLEOTIDES | UNIV COLUMBIA (US) | 2022-06-01 | — | — | EP | disclosed |
| US-10240195-B2 | Chemical methods for producing tagged nucleotides | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2019-03-26 | — | — | US | disclosed |
| US-20110111462-A1 | Composition and Method for Synthesizing a Deoxyribonucleotide Chain Using a Double Stranded Nucleic Acid Complex with a Thermostable Polymerase | ENZYMATICS, INC. | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110111462-A1 | Composition and Method for Synthesizing a Deoxyribonucleotide Chain Using a Double Stranded Nucleic Acid Complex with a Thermostable Polymerase | POLN, POLRMT, POLI | RNASE1 46/4885TK1 135/4885LMNA 651/4885 |
| US-10240195-B2 | Chemical methods for producing tagged nucleotides | NT5C3B, NCL, NUDT1 | RNASE1 405/4885TK1 333/4885LMNA 1284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.